Effects of Ca++ mobilization on expression of androgen-regulated genes: Interference with androgen receptor-mediated transactivation by AP-I proteins

Prostate

Volumn 33, Issue 4, 1997, Pages 264-270

  Murtha, Patricia E ^a   Zhu, Wen ^a   Zhang, Jianye ^a   Zhang, Shaobo ^a   Young, Charles Y F ^a  

^a MAYO CLINIC   (United States)

Author keywords

C jun; C los; HKLK2; Prostate; PSA

Indexed keywords

ANDROGEN RECEPTOR; CALCIMYCIN; CALCIUM ION; MESSENGER RNA; TRANSCRIPTION FACTOR AP 1;

ARTICLE; CALCIUM MOBILIZATION; EPITHELIUM CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MALE; NORTHERN BLOTTING; ONCOGENE C FOS; ONCOGENE C JUN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM;

ANDROGENS; BLOTTING, NORTHERN; CALCIMYCIN; CALCIUM; CELL LINE; CHLORAMPHENICOL O-ACETYLTRANSFERASE; GENE EXPRESSION REGULATION; GENES, FOS; GENES, JUN; HUMANS; IONOPHORES; KALLIKREINS; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; RECEPTORS, ANDROGEN; RNA, MESSENGER; TIME FACTORS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSFECTION;

EID: 0030817865     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(19971201)33:4<264::AID-PROS7>3.0.CO;2-H     Document Type: Article

References (30)

1. Isaacs JT, Lundmo PI, Berges R, Martikainen P, Kyprianou N, English HF: Androgen regulation of programmed death of normal and malignant prostatic cells. J Androl 1992;130:457-464.
2. Lindzey J, Kumar MV, Grossmann M, Young CYF, Tindall DJ: Molecular mechanisms of androgen action. Vitam Horm 1994; 49:383-432.
3. Young CYF, Andrews PE, Tindall DJ: Expression and androgenic regulation of human prostate-specific kallikreins. J Androl 1995;16:97-99.
4. Fong CJ, Sutkowski DM, Kozlowski JM, Lee C: Utilization of the Boyden chamber to further characterize in vitro migration and invasion of benign and malignant human prostatic epithelial cells. Invasion Metastasis 1992;12:266-274.
5. Tvedt KE, Kopstad G, Hangen OA, Halgunset J: Subcellular concentrations of calcium, zinc and magnesium in benign nodular hyperplasia of the humam prostate: X-ray microanalysis of freeze-dried cryosections. Cancer Res 1987;47:323-328.
6. Marti A, Jehn B, Costello E, Keon N, Ke G, Martin F, Jaggi R: Protein kinase A and AP-1 (c-Fos/JunD) are induced during apoptosis of mouse mammary epithelial cells. Oncogene 1994; 9:1213-1223.
7. Furuya Y, Lundmo P, Short AD, Gill DL, Isaacs JT: The role of calcium, pH and cell proliferation in the programmed (apoptotic) death of androgen-independent prostatic cancer cells induced by thapsigargin. Cancer Res 1994;54:6167-6175.
8. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol chloroform extraction. Anal Biochem 1987;162:156-159.
9. Young CYF, Andrews PE, Montgomery BT, Tindall DJ: Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein. Biochemistry 1992;31:818-829.
10. Bagchi MK, Tsai SY, Tsai MJ, O'Malley BW: Identification of a functional intermediate in receptor activation in progesterone-dependent cell-free transcription. Nature 1990;345:547-550.
11. Murtha PE, Tindall DJ, Young CYF: Androgen induction of a human prostate-specific kallikrein, hKLK2: Characterization of an androgen response element in the 5′ promoter region of the gene. Biochemistry 1993;32:6459-6464.
12. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt JJ, Drouin J, Karin M: Transcriptional interference between c-jun and the glucocorticoid receptor: Mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990;62: 1205-1215.
13. Tzukerman M, Zhang XK, Pfahl M: Inhibition of estrogen receptor activity by the tumor promoter 12-O-tetradeconyl-phorbol-13-acetate: A molecular analysis. Mol Endocrinol 1991; 5:1983-1992.
14. Schmidt EDL, Cramer SJ, Offringa R: The thyroid hormone receptor interferes with transcriptional activation via the AP-1 complex. Biochem Biophys Res Commun 1993;192:151-160.
15. Schüle R, Rangarajan PL, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM: Functional antagonism between oncoprotein c-jun and the glucocorticoid receptor. Cell 1990;62: 1217-1226.
16. Jonat G, Rahmsdorf HJ, Park KK, Cato ACB, Gebel S, Ponta H, Herrlich P: Antitumor promotion and anti-inflammation: Down-modulation of AP-1 (Fos/Jun) activity by glucocorticoid hormone. Cell 1990;62:1189-1204.
17. Riegman PH, Vlietstra RJ, van der Korput JA, Brinkmann AO, Trapman J. The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. Mol Endocrinol 1991;5:1921-1930.
18. Culig Z, Hobisch A, Cronauer MV, Radmayr C, Trapman J, Hittmair A, Bartsch G, Klocker H: Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-1, keratinocyte growth factor, and epidermal growth factor. Cancer Res 1994;54:5474-5478.
19. Zhang Y, Bai W, Allgood VE, Weigel NL: Multiple signaling pathways activate the chicken progesterone receptor. Mol Endrocrinol 1994;8:577-584.
20. Young CYF, Murtha PE, Andrews PE, Lindzey JK, Tindall DJ: Antagonism of androgen action in prostate tumor cells by retinoic acid. Prostate 1994;25:39-45.
21. Andrews PE, Young CYF, Montgomery BT, Tindall DJ: Tumor-promoting phorbol ester down-regulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line. Cancer Res 1992;52:1525-1529.
22. Bohmann D, Box TJ, Admon A, Nishimura T, Vogt PK, Tjian R: Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1. Science 1987;238:1386-1392.
23. Chiu R, Boyle WJ, Meek J, Smeal T, Hunter T, Karin M: The c-Fos protein interacts with c-Jun/AP-1 to stimulate transcription of AP-1 responsive genes. Cell 1988;54:541-552.
24. Franza BR Jr, Rauscher FJ III, Josephs SF, Curran T: The fos complex and fos-related antigens recognize sequence elements that contain AP-1 binding sites. Science 1988;239:1150-1153.
25. Rausher FJ III, Sambucetti LC, Curran T, Distel RJ, Spiegelman BM: A common DNA binding site for Fos protein complexes and transciption factor AP-1. Cell 1988;52:471-480.
26. Rauscher FJ III, Cohen DR. Curran T, Box TJ, Vogt PK, Bohmann D, Tjian R, Franza BR Jr: Fos-associated protein (p39) is the product of the jun proto-oncogene. Science 1988;240:1010-1016.
27. Young CYF, Murtha PE, Zhang J: Tumor-promoting phorbol ester-induced cell death and gene expression in a human prostate adenocarcinoma cell line. Oncol Res 1994;6:203-210.
28. Kallio PJ, Poukka H, Moilanen A, Jänne OA, Palvimo JJ: Androgen receptor-mediated transcriptional regulation in the absence of direct interaction with a specific DNA element. Mol Endocrinol 1995;9:1017-1028.
29. Gong Y, Blok LJ, Perry JE,Lindzey JK, Tindall DJ: Calcium regulation of androgen receptor expression in the human prostate cancer cell line LNCaP. Endocrinology 1995;136:2172-2178.
30. Metz R, Bannister AJ, Sutherland JA, hagemeier C, O'Rourke EC, Cook A, Bravo R, Kouzarides T: C-fos-induced activation of a TATA-box-containing promoter involves direct contact with TATA-box-binding protein. Mol Cell Biol 1994;14:6021-6029.